These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 23465021)
41. Recent Advances in the Development of New Therapeutic Tools Against Major Parasitic Diseases. De Simone G; D'Ambrosio K Curr Med Chem; 2018; 25(39):5238. PubMed ID: 30688176 [No Abstract] [Full Text] [Related]
42. Lessons from the History of Ivermectin and Other Antiparasitic Agents. Campbell WC Annu Rev Anim Biosci; 2016; 4():1-14. PubMed ID: 26515271 [TBL] [Abstract][Full Text] [Related]
43. Hybridization in Parasites: Consequences for Adaptive Evolution, Pathogenesis, and Public Health in a Changing World. King KC; Stelkens RB; Webster JP; Smith DF; Brockhurst MA PLoS Pathog; 2015 Sep; 11(9):e1005098. PubMed ID: 26336070 [No Abstract] [Full Text] [Related]
44. Integration of deworming into HIV care and treatment: a neglected opportunity. Gerns HL; Sangaré LR; Walson JL PLoS Negl Trop Dis; 2012; 6(7):e1738. PubMed ID: 22860143 [No Abstract] [Full Text] [Related]
50. Vorinostat as potential antiparasitic drug. Herrera-Martínez M; Orozco-Samperio E; Montaño S; Ariza-Ortega JA; Flores-García Y; López-Contreras L Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7412-7419. PubMed ID: 32706080 [TBL] [Abstract][Full Text] [Related]
51. [The approaches of the Russian school of parasitologists and immunologists to the therapy of parasitic diseases]. Ozeretskovskaia NN Med Parazitol (Mosk); 1998; (2):12-5. PubMed ID: 9691613 [No Abstract] [Full Text] [Related]
53. Price hikes could affect treatment for NTDs in the USA. Nelson R Lancet Infect Dis; 2018 Feb; 18(2):150-151. PubMed ID: 29412967 [No Abstract] [Full Text] [Related]
54. Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control. Keiser J; Ingram K; Utzinger J Parasitology; 2011 Oct; 138(12):1620-32. PubMed ID: 21349223 [TBL] [Abstract][Full Text] [Related]
55. Developing drugs for parasitic diseases. Andreopoulos S Science; 2003 Apr; 300(5618):430-1. PubMed ID: 12702858 [No Abstract] [Full Text] [Related]
56. Treatment of intestinal parasites in immigrants. Geltman P; Meyers A N Engl J Med; 1999 Jul; 341(5):377-8. PubMed ID: 10428671 [No Abstract] [Full Text] [Related]
57. Neglected parasitic infections: what every family physician needs to know. Woodhall D; Jones JL; Cantey PT; Wilkins PP; Montgomery SP Am Fam Physician; 2014 May; 89(10):803-11. PubMed ID: 24866216 [TBL] [Abstract][Full Text] [Related]
58. Exploring innovative ways to conduct coverage surveys for neglected tropical diseases in Malawi, Mali, and Uganda. Woodhall DM; Mkwanda S; Dembele M; Lwanga H; Drexler N; Dubray C; Harris J; Worrell C; Mathieu E Acta Trop; 2014 Apr; 132():119-24. PubMed ID: 24462795 [TBL] [Abstract][Full Text] [Related]
59. [New indications of ivermectin]. Caumes E; Danis M Rev Med Interne; 2001 Apr; 22(4):379-84. PubMed ID: 11586522 [TBL] [Abstract][Full Text] [Related]
60. Abstracts of the 2nd COST B22 Congress on Drug Discovery and Development for Parasitic Diseases, Siena, Italy, 29 September-1 October 2005. Parassitologia; 2005 Sep; 47 Suppl 1():3-128. PubMed ID: 16252442 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]